|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,410 KRW | 0.00% |
|
0.00% | -15.14% |
GeneOne Life Science, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 27,454.32 million compared to KRW 32,839.95 million a year ago. Net loss was KRW 77,768.04 million compared to KRW 38,150.07 million a year ago.
Basic loss per share from continuing operations was KRW 1,000 compared to KRW 492 a year ago. Basic loss per share was KRW 1,000 compared to KRW 492 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.14% | 142M | |
| +29.77% | 49.46B | |
| +1.00% | 42.58B | |
| +49.90% | 42.49B | |
| -5.26% | 29.09B | |
| +13.68% | 26.61B | |
| -22.99% | 18.64B | |
| +8.22% | 13.16B | |
| +32.41% | 12.55B | |
| -1.62% | 11.98B |
GENEONE LIFE SCIENCE, INC. 
